Vice President for Research at UT Health Science Center at San Antonio
Vice president, chief strategy and operating officer of the Texas Medical Center
Professor of Systems Biology, Columbia University
Chairman, CEO, & Founder, Alexandria Real Estate Equities
The San Diego Biotechnology Network has organized a presentation by Dan Shoemaker, the chief technology officer at Fate Therapeutics, and Stephen Chang, the chief scientific officer of Stemgent. They will give a short talk on the industrialization of advanced technology for drug discovery and development based on induced pluripotent stem cells. More information and online registration is here.